|Day Low/High||18.93 / 19.48|
|52 Wk Low/High||18.93 / 42.50|
Four posters highlight Mylan's rigorous research and development program
HERTFORDSHIRE, England and PITTSBURGH, May 17, 2019 /PRNewswire/ -- Mylan N.V.
Ogivri™ is the first biosimilar for Herceptin® approved by the U.S. Food and Drug Administration (FDA) for all indications including HER2-positive breast and gastric cancers
Attorneys general from 44 states allege the nation's largest generic drugmakers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs.
U.S. stock futures fall sharply after China vows to stand its ground in the escalating trade war with the United States; oil prices surge after Saudi Arabia alleges two of its tankers were victims of a 'sabotage attack,' Teva and other drugmakers are alleged to have conspired to artificially inflate and manipulate prices for generic drugs.
Erlotinib Hydrochloride Tablets treat metastatic non-small cell lung and pancreatic cancers
HERTFORDSHIRE, England and PITTSBURGH, May 10, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.
Mylan sinks after the company reports first-quarter revenue that misses analysts' expectations.
HERTFORDSHIRE, England and PITTSBURGH, May 7, 2019 /PRNewswire/ -- Mylan N.V.
Global stocks were mixed higher Tuesday, while U.S. equity futures drifted modestly into the red, as investors kept risk appetite in check ahead of a key series of trade talks between Washington and Beijing later this week that could define or collapse an elusive pact between the world's two largest economies.
HERTFORDSHIRE, England, and PITTSBURGH, April 26, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.
TB is a global epidemic responsible for 1.6 million deaths in 2017(1)
HERTFORDSHIRE, England and PITTSBURGH, April 3, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.
ROCKFORD, Ill., March 18, 2019 /PRNewswire/ -- Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level.
Money to Aid Ongoing Recovery Efforts in Puerto Rico, Funding the Rebuild and Repair of at Least 100 Homes
HERTFORDSHIRE, England and PITTSBURGH, Feb. 28, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.
Shares of Mylan tumble after the generic drugmaker misses Wall Street's fourth-quarter earnings and 2019 forecast expectations.
HERTFORDSHIRE, England and PITTSBURGH, Feb. 26, 2019 /PRNewswire/ -- Mylan N.
U.S. stock futures decline amid a series of geopolitical risks that trimmed risked appetite; Federal Reserve Chairman Jerome Powell will testify before a Senate committee on Tuesday; the SEC asks a judge to hold Tesla's Elon Musk in contempt of court; Home Depot, Macy's and Palo Alto Networks report earnings.
HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.
HERTFORDSHIRE, England, and PITTSBURGH, Feb. 11, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.
Wixela™ Inhub™ is the first FDA-approved therapeutically equivalent generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or chronic obstructive pulmonary disease (COPD)
HERTFORDSHIRE, England and PITTSBURGH, Dec. 20, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.
Mesalamine Delayed-Release Tablets help individuals manage their ulcerative colitis.
Mylan's Mesalamine Rectal Suppository treats mildly to moderately active ulcerative proctitis
Mylan achieves key milestone to provide U.S. diabetes patients with more affordable generic version of Sanofi's Lantus® insulin glargine vials
HERTFORDSHIRE, England and PITTSBURGH, Dec. 4, 2018 /PRNewswire/ -- Mylan N.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.